BIO congratulates US Chief Agricultural Negotiator Richard Crowder and his staff for negotiating a separate understanding on several agricultural biotechnology issues. The FTA will go a long way in providing additional market access opportunities in Korea for US biotechnology companies.
Dr. Michael K Hansen, from US Centre of Consumer Policy, advises a cautious attitude towards an FTA with the US as the US has a hidden agenda in seeking to protect its farmers who now face more than RM4.6 billion in losses due to the lack of demand for GE rice.
The South Korean government pledged to ease quarantine rules on products containing genetically modified organisms (GMOs) under a free trade agreement with the United States struck on April 2. But while negotiations were underway on the deal, the government denied it was discussing the topic.
South Korea has reportedly exempted US foods containing genetically modified organisms (GMOs) from safety tests in the Korea-US free trade agreement struck on April 2, a move that Korean environmentalists criticised as the government "selling off" the health of the nation.
Consumers Association of Penang is extremely concerned and anxious that Malaysia’s Biosafety Bill and an amendment to the Food Regulations are now threatened by proposals made in the negotiations for a free trade agreement with the United States.
The Malaysian government has been urged not to bend to US pressure, under their bilateral FTA talks, to scrap its proposed laws that would bring in mandatory labeling of genetically-modified (GM) foods.
With maize trade scheduled to be fully liberalized under NAFTA in 2008, many farm groups are
calling for a renegotiation of the treaty’s agricultural provisions to prevent further
damage. This analysis examines the room for alternative policies in Mexico under
existing economic and environmental agreements, including NAFTA. It concludes that
the Mexican government retains access to many useful policy instruments that could
promote rural livelihoods while arresting the losses of important maize diversity. What is
lacking is the political will to make use of them.
Depuis la signature en 1994 de l’Accord de libre-échange nord-américain (ALENA), le Mexique est devenu plus dépendant du maïs américain subventionné. Ainsi, l’augmentation de la production d’éthanol aux États-Unis a considérablement réduit l’approvisionnement en maïs à des fins de consommation, poussant les prix à la hausse, au Mexique comme à l’échelle internationale.
Paper presented to the European Commission in Brussels by Liepollo Lebohang Pheko from IGTN-Africa on the gender impacts of liberalization of Economic Partnership Agreements (EPA).
Mexico has moved to ban experimental fields of genetically modified (GM) maize. But the gateway into Mexico of transgenic maize, in the form of unlabeled grain imports, remains ajar. In 2008, as part of NAFTA, the quotas and other barriers for the entry of US-grown GM maize and beans into Mexico will be eliminated.
This new briefing from GRAIN and the African Centre for Biosafety looks at how governments, the agribusiness sector and transnational companies are increasingly using bilateral trade agreements to prise open markets for genetically modified crops.
Bilateral and unilateral, initiatives are the new avatars of globalisation and free trade. And it is these avatars we must challenge to stop corporate rule, while WTO hangs between intensive care and the crematorium.
Agreement between the US, Canada, and Mexico with respect to the documentation requirements of the Cartagena Protocol on Biosafety pertaining to living modified organisms intended for direct use as food or feed or for processing (LMO/FFPs), signed in October 2004.
South Korea and the US have agreed to establish a standing committee on sanitary standards for agricultural and food products, which will make it easier for the US to ask for expanded trade of genetically modified crops. However, negotiations on pharmaceuticals have hit a snag, with neither side willing to budge.
Letter from the US Biotechnology Industry Organisation to the US Trade Representative on intellectual property, GM labelling, biosafety, GM contamination and other issues BIO wants addressed under the US-Korea FTA talks.
Letter from the US Biotechnology Industry Organisation to the US Trade Representative on intellectual property, GM labelling, biosafety, GM contamination and other issues BIO wants addressed under the US-Malaysia FTA talks.
Bilateral free trade agreements are seen by the agricultural biotechnology industry as an
important conduit for spreading genetically modified organisms (GMOs) around the world.